Literature DB >> 16675789

Community acquired pneumonia in primary care.

Herman Goossens, Paul Little.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675789      PMCID: PMC1458613          DOI: 10.1136/bmj.332.7549.1045

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  12 in total

Review 1.  Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections.

Authors:  K Loens; D Ursi; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children.

Authors:  J Domínguez; S Blanco; C Rodrigo; M Azuara; N Galí; A Mainou; A Esteve; A Castellví; C Prat; L Matas; V Ausina
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

3.  Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard".

Authors:  Matthias F C Beersma; Kristien Dirven; Alje P van Dam; Kate E Templeton; Eric C J Claas; Herman Goossens
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 4.  Guidelines for the management of adult lower respiratory tract infections.

Authors:  M Woodhead; F Blasi; S Ewig; G Huchon; M Ieven; M Leven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; T J M Verheij
Journal:  Eur Respir J       Date:  2005-12       Impact factor: 16.671

Review 5.  Pneumonia: update on diagnosis and management.

Authors:  Zara Hoare; Wei Shen Lim
Journal:  BMJ       Date:  2006-05-06

6.  Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002).

Authors:  R H Vander Stichele; M M Elseviers; M Ferech; S Blot; H Goossens
Journal:  J Antimicrob Chemother       Date:  2006-05-12       Impact factor: 5.790

Review 7.  Community acquired infections and bacterial resistance.

Authors:  H Goossens; M J Sprenger
Journal:  BMJ       Date:  1998-09-05

8.  Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community.

Authors:  J Macfarlane; W Holmes; P Gard; R Macfarlane; D Rose; V Weston; M Leinonen; P Saikku; S Myint
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

Review 9.  Antibiotics for acute bronchitis.

Authors:  J Smucny; T Fahey; L Becker; R Glazier
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

10.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

View more
  5 in total

1.  Pneumonia: let's avoid confusion of secondary and primary care issues in pneumonia.

Authors:  Wei Shen Lim; Zara Hoare
Journal:  BMJ       Date:  2006-05-20

2.  Pneumonia: ... and to tuberculosis as differential diagnosis in community acquired pneumonia.

Authors:  Takeharu Koga; Hisamichi Aizawa
Journal:  BMJ       Date:  2006-05-20

3.  Evaluation and significance of C-reactive protein in the clinical diagnosis of severe pneumonia.

Authors:  Jianjun Wu; Y U Jin; Hailong Li; Zhiping Xie; Jinsong Li; Yuanyun Ao; Zhaojun Duan
Journal:  Exp Ther Med       Date:  2015-05-12       Impact factor: 2.447

4.  Efficacy of pneumococcal vaccination in adults: a meta-analysis.

Authors:  Anke Huss; Pippa Scott; Andreas E Stuck; Caroline Trotter; Matthias Egger
Journal:  CMAJ       Date:  2009-01-06       Impact factor: 8.262

5.  Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.

Authors:  Beat Müller; Stephan Harbarth; Daiana Stolz; Roland Bingisser; Christian Mueller; Jörg Leuppi; Charly Nusbaumer; Michael Tamm; Mirjam Christ-Crain
Journal:  BMC Infect Dis       Date:  2007-03-02       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.